Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
16.45
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
16.44
-0.01 (-0.06%)
After-hours: Apr 28, 2026, 7:22 PM EDT
Select Medical Holdings Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Select Medical Holdings stock have an average target of 15.17, with a low estimate of 14 and a high estimate of 16.5. The average target predicts a decrease of -7.78% from the current stock price of 16.45.
Analyst Consensus: Buy
* Price targets were last updated on Mar 3, 2026.
Analyst Ratings
The average analyst rating for Select Medical Holdings stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 2 | 2 | 2 | 1 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 4, 2026 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $19 → $17 | Buy → Hold | Downgrades | $19 → $17 | +0.30% | Mar 3, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +15.50% | Feb 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | +21.58% | Oct 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | -8.81% | Sep 10, 2025 |
Financial Forecast
Revenue This Year
5.75B
from 5.45B
Increased by 5.45%
Revenue Next Year
6.03B
from 5.75B
Increased by 4.78%
EPS This Year
1.28
from 1.16
Increased by 9.83%
EPS Next Year
1.38
from 1.28
Increased by 7.84%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.0B | 6.3B | |
| Avg | 5.8B | 6.0B | |
| Low | 5.5B | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.1% | 10.0% | |
| Avg | 5.4% | 4.8% | |
| Low | 1.7% | 0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.46 | 1.58 | |
| Avg | 1.28 | 1.38 | |
| Low | 1.15 | 1.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 25.3% | 23.1% | |
| Avg | 9.8% | 7.8% | |
| Low | -1.6% | -13.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.